Companies reduce prices for HIV drugs in developing countries

被引：0

|

作者：

Gottlieb, S

机构：

来源：

BULLETIN OF THE WORLD HEALTH ORGANIZATION | 2000年 / 78卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

收藏

页码：862 / 862

页数：1

相关论文

共 50 条

[1] Drug companies cut HIV drug prices in the developing world
Yamey, G
[J]. BRITISH MEDICAL JOURNAL, 2000, 320 (7246): : 1357 - 1357
[2] Philippines joins other developing countries in limiting prices of drugs
Bland, Ben
[J]. BRITISH MEDICAL JOURNAL, 2009, 339
[3] Pricing and patents of HIV/AIDS drugs in developing countries
Borrell, Joan-Ramon
[J]. APPLIED ECONOMICS, 2007, 39 (4-6) : 505 - 518
[4] Can WHO provide guidance on HIV drugs for developing countries?
Karen Birmingham
[J]. Nature Medicine, 2002, 8 : 429 - 429
[5] Do patents prevent access to drugs for HIV in developing countries?
Boelaert, M
Lynen, L
Van Damme, W
Colebunders, R
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (07): : 840 - 841
[6] Can WHO provide guidance on HIV drugs for developing countries?
Birmingham, K
[J]. NATURE MEDICINE, 2002, 8 (05) : 429 - 429
[7] Developing drugs for developing countries
Ridley, DB
Grabowski, HG
Moe, JL
[J]. HEALTH AFFAIRS, 2006, 25 (02) : 313 - 324
[8] Sugar prices reduce profits of sugar companies
不详
[J]. SUGAR INDUSTRY-ZUCKERINDUSTRIE, 2014, 139 (02): : 76 - 76
[9] Drug companies should cut prices for developing countries, says G8 report
Walgate, R
[J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2003, 81 (01) : 72 - 73
[10] INTERNATIONAL COMPANIES IN THE DEVELOPING-COUNTRIES
STICH, H
[J]. SIEMENS REVIEW, 1980, 47 (05): : 30 - 32

← 1 2 3 4 5 →